Literature DB >> 21372667

Current options in the management of complex abdominal wall defects.

Bahair Ghazi1, Olivier Deigni, Maksym Yezhelyev, Albert Losken.   

Abstract

The management of complex abdominal wall defects is challenging and often requires an individualized strategy with additional measures to minimize morbidity and recurrence. We retrospectively reviewed all patients who underwent reconstruction of complex abdominal wall defects at Emory Hospital by the senior author over a 7-year period. Abdominal hernia defects were categorized into primary, secondary, and tertiary hernias; infection; composite tumor defects; and dehiscence. Charts were queried for comorbidities, surgical technique, and outcome measures such as complications and recurrence. A total of 165 patients included in the series, with an average age of 52 years, and an average body mass index of 38 kg/m. Mesh was used in 81.8% of cases, 77% of those (mesh) being acellular dermal matrices (ADM). Component separation was performed in 75 patients (45.4%). The overall complication rate was 23.6% (39/165) including infection, delayed healing, skin necrosis, and fistulae, and was higher in patients with 2 or more comorbidities and those who required synthetic mesh reconstruction. The hernia recurrence or bulge was observed in 20.6% (34/165), and 29.4% of these patients required an additional, equally complex procedure. Hernia recurrence was significantly associated with a history of previous recurrent hernia, and hypertension (P < 0.04 and P = 0.001, respectively). Recurrence was higher in patients with 2 or more comorbidities (26% vs. 14%, P = 0.022). The recurrence rate was similar for synthetic and ADM reconstructions; however, the complication rates were higher when synthetic mesh was used. Attention to surgical technique, optimization of comorbidities, and the increased use of biologic meshes will minimize the need for operative intervention of complications following reconstruction of complex abdominal wall defects. Components separation and ADM have been very useful additions to the surgical management in these high-risk patients.

Entities:  

Mesh:

Year:  2011        PMID: 21372667     DOI: 10.1097/SAP.0b013e31820d18db

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  20 in total

Review 1.  A novel tool to evaluate bias in literature on use of biologic mesh in abdominal wall hernia repair.

Authors:  J Con; L Zarain; S Gogna; D J Samson; K Prabhakaran; S Gashi; E Tilley; R Latifi
Journal:  Hernia       Date:  2019-04-08       Impact factor: 4.739

2.  Analysis of perioperative factors associated with increased cost following abdominal wall reconstruction (AWR).

Authors:  John P Fischer; Ari M Wes; Jason D Wink; Jonas A Nelson; Jeff I Rohrbach; Benjamin M Braslow; Stephen J Kovach
Journal:  Hernia       Date:  2014-07-20       Impact factor: 4.739

3.  Prevalence of systemic inflammation and micronutrient imbalance in patients with complex abdominal hernias.

Authors:  Abby K Geletzke; John M Rinaldi; Brett E Phillips; Sarah B Mobley; Jamie Miller; Thomas Dykes; Christopher Hollenbeak; Shannon L Kelleher; David I Soybel
Journal:  J Gastrointest Surg       Date:  2013-12-20       Impact factor: 3.452

Review 4.  A meta-analysis comparing open anterior component separation with posterior component separation and transversus abdominis release in the repair of midline ventral hernias.

Authors:  J D Hodgkinson; C A Leo; Y Maeda; P Bassett; S M Oke; C J Vaizey; J Warusavitarne
Journal:  Hernia       Date:  2018-03-07       Impact factor: 4.739

Review 5.  A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions.

Authors:  F E Primus; H W Harris
Journal:  Hernia       Date:  2013-01-08       Impact factor: 4.739

6.  The use of an acellular porcine dermal collagen implant in the repair of complex abdominal wall defects: a European multicentre retrospective study.

Authors:  P Giordano; R D Pullan; B Ystgaard; F Gossetti; M Bradburn; A J McKinley; N J Smart; I R Daniels
Journal:  Tech Coloproctol       Date:  2015-06-17       Impact factor: 3.781

7.  Wound risk assessment in ventral hernia repair: generation and internal validation of a risk stratification system using the ACS-NSQIP.

Authors:  J P Fischer; J D Wink; C T Tuggle; J A Nelson; S J Kovach
Journal:  Hernia       Date:  2014-12-04       Impact factor: 4.739

8.  Autologous reconstruction of the inguinal ligament using pedicled fascia lata flap: A new technique.

Authors:  Alasdair R Bott; Shaheel Chummun; Rory F Rickard; Andrew N Kingsnorth
Journal:  Int J Surg Case Rep       Date:  2013-05-30

Review 9.  Biologic versus nonbiologic mesh in ventral hernia repair: a systematic review and meta-analysis.

Authors:  Ali Darehzereshki; Melanie Goldfarb; Joerg Zehetner; Ashkan Moazzez; John C Lipham; Rodney J Mason; Namir Katkhouda
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

10.  Component separation with porcine acellular dermal reinforcement is superior to traditional bridged mesh repairs in the open repair of significant midline ventral hernia defects.

Authors:  Bryan Richmond; Adam Ubert; Rudy Judhan; Jonathan King; Tanner Harrah; Benjamin Dyer; Stephanie Thompson
Journal:  Am Surg       Date:  2014-08       Impact factor: 0.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.